Krilogy Financial LLC Has $1.41 Million Stake in SPDR S&P Biotech ETF $XBI

Krilogy Financial LLC trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 83.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,391 shares of the exchange traded fund’s stock after selling 50,716 shares during the period. Krilogy Financial LLC’s holdings in SPDR S&P Biotech ETF were worth $1,408,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. AQR Capital Management LLC boosted its stake in SPDR S&P Biotech ETF by 77.1% in the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after acquiring an additional 2,167 shares during the last quarter. Marshall Wace LLP raised its position in shares of SPDR S&P Biotech ETF by 102.3% during the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after acquiring an additional 179,029 shares during the last quarter. The Manufacturers Life Insurance Company bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at $260,000. Ameriprise Financial Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 123.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after purchasing an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 3.7% in the 2nd quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after purchasing an additional 193 shares during the period.

SPDR S&P Biotech ETF Stock Up 1.3%

NYSEARCA:XBI opened at $151.59 on Friday. SPDR S&P Biotech ETF has a 12-month low of $82.04 and a 12-month high of $154.70. The firm has a market capitalization of $9.67 billion, a P/E ratio of 11.47 and a beta of 0.85. The stock’s fifty day simple moving average is $134.86 and its 200-day simple moving average is $128.51.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.